Engagement of the TCR (T-cell receptor) induces tyrosine phosphorylation of the LAT (linker for the activation of T-cells) adaptor, and thereby it recruits several cytosolic mediators for downstream signalling pathways. The Fas protein is essential for T-lymphocyte apoptosis, and following Fas engagement, many proteins are proteolytically cleaved, including several molecules that are important for the transduction of TCR intracellular signals. In the present study, we demonstrate that the adaptor LAT is also subject to a proteolytic cleavage in mature T-lymphocytes and thymocytes in response to Fas engagement, and also on TCR stimulation, and we identify three aspartic acid residues at which LAT is cleaved. Interestingly, these aspartic acid residues are located in proximity to several functionally important tyrosine residues of LAT, raising the possibility that their phosphorylation could modulate LAT cleavage. Consistent with that hypothesis, we show that induction of phosphorylation by pervanadate or H 2 O 2 in Jurkat cells and thymocytes inhibits Fas-mediated cleavage of LAT. Moreover, we show that LAT proteolysis is also enhanced during anergy induction of primary human T-cells, suggesting that LAT cleavage may act as a regulator of TCR-mediated activation of T-cells and not only as a transducer of cell death promoting stimuli.
INTRODUCTION
T-lymphocytes detect foreign peptides bound to MHC via the TCR (T-cell receptor) and convey this information to the inside of the cell through its associated CD (cluster of differentiation) 3 subunits. TCR engagement triggers phosphorylation of ITAM (immunoreceptor tyrosine-based activation motif) in the CD3 subunits, which on phosphorylation recruit ZAP-70 [ζ -chain (TCR)-associated protein kinase of 70 kDa] tyrosine kinase to the membrane, leading to the phosphorylation of several intracellular substrates, including the LAT (linker for the activation of Tcells) adaptor [1] [2] [3] . LAT is an integral transmembrane adaptor protein of 36-38 kDa expressed in peripheral T-lymphocytes, thymocytes, NK (natural killer) cells, mast cells, platelets and pre-B-cells [4] . Many of the functions of LAT are carried out by its four conserved C-terminal tyrosine residues, which on phosphorylation constitute docking sites for a number of cytosolic signalling effectors [4] [5] [6] [7] . These tyrosine residues are essential for the transduction of intracellular signals generated by the TCR-CD3 complex in developing and mature T-cells [8] [9] [10] [11] . Aside from tyrosine resides, other amino acids in LAT can be phosphorylated [12, 13] . Indeed, we recently showed that several serine residues of LAT are essential for TCRmediated activation of both PLC (phospholipase C)-γ 1 and MAPK (mitogen-activated protein kinase) [14] . Once recruited to the LAT signalosome, PLCγ 1 and other signalling effectors are then activated, leading to Ca 2 + mobilization and activation of multiple pathways, which in turn activate specific nuclear factors leading to anergy, or alternatively, to survival, activation, proliferation and differentiation of T-lymphocytes into effector cells [15] [16] [17] .
In the course of immune responses, antigen-specific T-cells are activated and first undergo a phase of clonal expansion, followed by a contraction phase that restores normal T-cell numbers and requires apoptosis [18] . Apoptosis is a form of programmed cell death that is essential for many relevant biological processes [19] . There exist two major mechanisms of apoptosis that operate through the intrinsic and the extrinsic pathways. The intrinsic pathway is usually triggered in response to severe cell stress events such as DNA damage or withdrawal of survival factors and involves release of pro-apoptotic proteins from the mitochondria to the cytosol and activation of caspase enzymes [20] . In contrast, the extrinsic pathway is typically initiated upon engagement of members of the TNFR (tumour necrosis factor receptor) family. For instance, binding of Fas, also known as CD95 or APO-1 (apoptosis antigen 1), to its ligands leads to the recruitment and activation of caspase-8, which in turn activates effector caspases [21] .
Although Fas engagement is essential for T-lymphocyte apoptosis and immune system homoeostasis [18] , it can also transduce activation signals leading to T-cell proliferation on TCR engagement [22] . Paradoxically, it had been demonstrated previously that the simultaneous engagement of TCR, CD28 and Fas in naive human T-lymphocytes led to decreased activation Abbreviations used: CD, cluster of differentiation; ECL, enhanced chemiluminescence; ERK, extracellular-signal-regulated kinase; -fmk, fluoromethylketone; FBS, fetal bovine serum; GFP, green fluorescent protein; Grb2, growth-factor-receptor-bound protein 2; IL, interleukin; IRES, internal ribosome entry site; LAT, linker for the activation of T-cells; mAb, monoclonal antibody; PARP, poly(ADP-ribose) polymerase; PBMC, peripheral blood mononuclear cell; PHA, phytohaemagglutinin; PKC, protein kinase C; PLC, phospholipase C; SIN, self-inactivating; SLP-76, Src homology 2 domaincontaining leucocyte protein of 76 kDa; TCR, T-cell receptor; ZAP-70, ζ-chain (T-cell receptor)-associated protein kinase of 70 kDa; z-, benzyloxycarbonyl-3. 1 To whom correspondence should be addressed (email enrique.aguado@uca.es).
and proliferation [23] . In these cells, Fas triggering is able to disrupt the TCR signalling pathway by inhibiting recruitment of ZAP-70, PLC-γ 1 and PKC (protein kinase C)-θ . Considering that Fas engagement results in cleavage of Gads (GRB2-related adaptor protein 2), LAT and SLP-76 (Src homology 2 domain-containing leucocyte protein of 76 kDa) adaptors, the present study analysed whether the negative impact of Fas engagement on TCR signalling resulted in Fas-mediated cleavage of LAT. LAT seems to be cleaved by a caspase-mediated process in response to Fas engagement, CD3 cross-linking and by treatment of cells with the PKC inhibitor staurosporine. LAT cleavage takes place at three aspartic acid residues located in close proximity to several functionally important tyrosine residues. Interestingly, phosphorylation of these tyrosine residues blocks Fas-mediated cleavage, whereas Fas triggering prevents early intracellular signals associated with the TCR-CD3 complex, suggesting a previously unrecognized negative regulatory loop that involves cleavage of LAT which is dependent on the state of LAT tyrosine phosphorylation. were from Cell Signaling Technology; anti-phosphotyrosine RC20 was from Transduction Laboratories; and anti-Grb2 (growth-factor-receptor-bound protein 2) and anti-phospho-LATTyr 132 were obtained from Abcam. Monoclonal mouse antiIgG1 anti-β-actin antibody peroxidase conjugate was from Sigma-Aldrich; and monoclonal anti-mouse-CD69 antibody PE (phycoerythrin) was from BD Bioscience.
Mutation of LAT was performed with GeneTailor TM SiteDirected Mutagenesis System (Invitrogen) with specific pairs of primers. Mutagenesis was performed using a pENTR11 plasmid (Invitrogen) containing the cDNA for wild-type LAT as a template, followed by a linker containing a 6×His-tag 5 and an IRES (internal ribosome entry site) sequence [14] . DNAs encoding wild-type or mutant LAT-6×His-IRES were subcloned in-frame with GFP (green fluorescent protein) in the SIN (selfinactivating) lentiviral transfer plasmid pHR'SIN-cPPT-Blast by means of site-specific recombination (Gateway LR Clonase, Invitrogen). The coding sequences of all LAT constructs were verified by sequencing. The lentiviral transfer plasmid for the expression of the wild-type LAT-GFP fusion protein has been described recently [14] .
Reagents
Ionomycin and PHA (phytohaemagglutinin) were purchased from Sigma-Aldrich. The peptide caspase inhibitors z-VAD-fmk (where z-is benzyloxycarbonyl-and -fmk is -fluoromethylketone), z-VDVAD-fmk (caspase 2), Ac (N-acetyl)-DEVD-cmk (chloromethylketone) (caspase 3-III), z-DQMD-fmk (caspase 3-V), z-IETD-fmk (caspase 8/granzyme B) and z-LEHD-fmk were purchased from Calbiochem. IL-2 (interleukin 2) was obtained through the AIDS Research and Reference Reagent Program, Division of AIDS; NIAID; NIH.
Cell lines and PBMC (peripheral blood mononuclear cell) isolation and culture
Jurkat cells, the LAT-deficient JCaM2 cell line (generously provided by Dr Arthur Weiss, UCSF, San Francisco, CA, U.S.A.), and subsequent stable transfectant lines were maintained as described in [24] . VL3-3M2 cells were maintained as described previously [25] . Human peripheral blood samples were obtained from healthy donors with informed consent of the subjects and following ethical approval. PBMCs were obtained from buffy coats of normal individuals by Ficoll-Hypaque density-gradient centrifugation. PBMCs (24×10 6 ) were then cultured for 1 week in the presence of 1 μg/ml of PHA and 40 international units/ml of recombinant IL-2 before anergy induction.
Thymocytes isolation and culture
For isolation of mouse thymocytes, thymi from C57Bl/6 mice were dissected and ground through a 70-μm cell strainer and washed twice in PBS. All procedures using mice were approved by the First Local Ethical Commission in Wrocław, Poland, under permission number 06/2009.
In vitro induction of anergy in CD4 T-cells with ionomycin
CD4 T-cells were purified from cultured PBMCs with Dynabeads Untouched TM Human CD4 T Cells kit (Invitrogen), and then with ionomycin (Sigma-Aldrich) at a final concentration of 1 μM for 16 h in DMEM (Dulbecco's modified Eagle's medium) with 10 % FBS (fetal bovine serum) at a concentration of 2×10 6 cells/ml in a volume of 2 ml. Anergy induction in these cells was evaluated by the proliferative capacity in response to plate-bound anti-CD3 and anti-CD28 antibodies, measured with the Click-iT EdU Flow Cytometry Assay Kit (Invitrogen) following instructions from the producer. cells/ml) in 6-well plates. Lentiviral supernatant was added, and cells were cultured for 48 h in a 37
• C and 5 % CO 2 incubator. After selection with 10 μg/ml blasticidin, expression of LAT and GFP was analysed by FACS.
Anti-CD3 and anti-Fas stimulation and preparation of cell lysates
JCaM2 transfected cells were starved overnight in RPMI 1640 medium without FCS for five times, then stimulated with OKT3 anti-CD3 mAb (eBioscience) in RPMI 1640 at 37
• C. Cells (2.5×10 7 cells/ml) were then lysed in 2× Laemmli buffer, followed by incubation at 95
• C for 5 min and sonication. For anti-Fas stimulation, cells were incubated with the indicated concentrations of anti-Fas mAb at 1×10 6 cells/ml in RPMI 1640 supplemented with 10 % FBS, and then pelleted and lysed as described above. When needed, cells were treated with freshly prepared 1 % pervanadate (10 mM Na 3 VO 4 containing 1 % H 2 O 2 ) for 5 min at 37
• C.
SDS/PAGE and Western blotting
For LAT detection by Western blot analysis, whole cell lysates from 10 6 transfectant cells were obtained by resuspending cells in Laemmli lysis buffer and separated in SDS/PAGE gels and transferred on to PVDF membranes. The membranes were incubated with the indicated primary antibodies followed by the appropriate secondary antibody conjugated to horseradish peroxidase. Reactive proteins were visualized using the ECL (enhanced chemiluminescence) system and exposition to Hyperfilm ECL (GE Healthcare) or directly acquired with VersaDoc 5000 Imaging System (Bio-Rad Laboratories). For reprobing, PVDF membranes were incubated for 10 min at room temperature (25
• C) with 0.1 M NaOH, followed by thorough washes with blocking buffer.
Measurement of intracellular Ca 2 + mobilization
Measurement of intracellular free Ca 2 + was carried out using Indo-1 AM (acetoxymethyl) (2 μM; Molecular Probes, Invitrogen) as described recently [14] . Calcium measurements were performed using a Synergy MX Multi-Mode Reader (Biotek) at 37
• C. The cells were excited by light at a wavelength of 340 nm, and the fluorescence emitted at 405 and 485 nm was collected alternately per second. Calcium mobilization was evaluated by the ratio of 405/485 nm fluorescence signal.
Statistical analysis
Data are expressed as means + − S.E.M. Statistical differences in the results for the different parameters between groups were evaluated by the two-tailed Student's t test. A P value of <0.05 was considered significant.
RESULTS

The adaptor LAT is proteolytically cleaved on Fas engagement
LAT is proteolytically cleaved in T-cells following Fas crosslinking [24, 25] . In order to analyse the cleavage of LAT, we transfected LAT-deficient JCaM2 cells with a lentiviral vector coding for wild-type LAT in frame with a 6×His tag and containing an IRES-GFP cassette [14] (upper panel, Figure 1A ). Treatment of transfected cells with anti-Fas mAb for 2 h induced the appearance of a LAT cleavage product of approximately 25-30 kDa. A 4-h treatment produced the appearance of two bands with electrophoretic mobilities of approximately 25-30 kDa and 18-20 kDa respectively (lower left-hand panel, Figure 1A ). In order to verify that LAT cleavage was not the result of a nonspecific increase in proteolytic activity, we analysed the same cell lysates for the presence of cleaved Grb2 molecules. Consistent with previous data [26, 27] , Grb2 was not cleaved in response to Fas engagement (lower right-hand panel, Figure 1A ).
We then studied whether LAT was also cleaved in peripheral T-lymphocytes following Fas engagement. Freshly isolated PHA plus IL-2 activated PBMCs were left untreated or treated with anti-Fas mAb, staurosporine or plate-bound anti-CD3 antibodies.
As shown in Figure 1 (B), resting and activated PBMCs also show a modest cleavage of LAT following anti-Fas mAb or staurosporine treatments. Interestingly, CD3 cross-linking for 16 h also induces cleavage of LAT in activated T-cells.
As the 06-807 polyclonal antibody recognizes both human and mouse LAT, we also analysed LAT cleavage in thymocytes from C57Bl/6 mice. LAT is cleaved in thymocytes upon CD3 and Fas cross-linking (upper panel, Figure 1C ). Interestingly, untreated thymocytes also show some cleavage of LAT after 3 h of culture, although the intensity of this is weaker than the one observed in anti-CD3-or anti-CD95-treated cells (see the equal protein load in the β-actin Western blot in lower panel of Figure 1C ).
LAT is cleaved by a caspase or granzyme-B-mediated process
Given that the LAT adaptor is cleaved on Fas cross-linking, we wanted to analyse the involvement of caspases. Therefore we analysed whether the general caspase inhibitor z-VAD-fmk affected LAT cleavage. As shown in Figure 2 (A), z-VADfmk treatment of LAT plus JCaM2 cells prevented Fas-mediated LAT cleavage. To identify the protease(s) responsible for Fasmediated LAT cleavage, LAT plus JCaM2 were incubated with inhibitors specific for caspases 2, 3, 9 and 8/granzyme-B. As shown in Figure 2 (B), inhibition of caspase 8/granzyme B with z-IETD-fmk almost totally abrogated LAT rupture. Also, inhibition of caspases 3 and 9 modestly reduced Fas-mediated LAT cleavage, but this effect could be due to 'cross-inhibition' of caspase 8 or granzyme B [28] . In contrast, inhibition of caspase 2 barely affected LAT cleavage. We also analysed whether LAT cleavage could be inhibited by caspase inhibitors in mouse thymocytes. As shown in Figure 2 (C), treatment with the general caspase inhibitor z-VAD-fmk blocked LAT cleavage induced by dexamethasone in mouse thymocytes. Interestingly, although inhibition of caspase 2 did not affect LAT cleavage, treatment with caspase 8/granzyme B inhibitor reduced LAT cleavage ( Figure 2C ). Together, these data suggest that caspase 8 or granzyme B are implicated in LAT cleavage.
Proteolytic cleavage generates discrete N-terminal fragments of LAT
To characterize LAT fragments resulting from its cleavage, we compared the size of fragments generated in JCaM2 cells expressing wild-type LAT or LAT molecules fused at their Cterminus with a GFP or a 6×His tag (upper panel, Figure 2D ). Following a 4-h treatment with anti-Fas antibodies, cells were lysed and analysed for LAT cleavage by Western blotting. As shown in Figure 2 (D), proteolytic fragments generated in LAT-GFP, LAT-6×His and wild-type LAT-expressing cells had exactly the same electrophorectic mobility. This result, together with the fact that the 06-807 anti-LAT antibody used in the Western blot was generated against a peptide corresponding to a sequence near the N-terminus of the human LAT, demonstrates that the observed LAT fragments correspond to N-terminal portions of this adaptor molecule.
LAT is cleaved at three discrete aspartic acid residues
To predict the amino acid residues at which LAT is cleaved, we took into account the specificity of caspase 8/granzyme B inhibitors, but also the size of the fragments resulting from LAT cleavage. By combining these prerequisites with the use of the MEROPS database [29] , we determined candidate caspase 8/granzyme B cleavage sites in the LAT sequence ( Figure 3A) . 
Asp
138 and Asp 225 residues in human LAT constituted the best candidates for LAT cleavage sites. Mutating each of them into alanine demonstrated that the mutation of Asp 225 had no effect on LAT cleavage, whereas mutation of Asp 138 into an alanine prevented the generation of the 18-20 kDa band following Fas cross-linking ( Figure 3B) . Analysis of the additional aspartic acid residues found at position 160, 169, 170 and 186 showed that mutation of Asp 186 residue was sufficient to prevent the appearance of the 25-30 kDa fragment ( Figure 3B) . Surprisingly, simultaneous mutation of Asp 138 and Asp 186 residues did not prevent LAT cleavage, since in this mutant Fas cross-linking induced the appearance of a band of ∼16 kDa, not observed in LAT wild-type expressing cells (lower left-hand panel, Figure 3B ). Given the size of this band, we hypothesized that this fragment should be generated by a cleavage at Asp 126 . Indeed, simultaneous mutation of Asp 126 , Asp 138 and Asp 186 totally blocked LAT cleavage on Fas engagement in transfected JCaM2 cells (lower right-hand panel, Figure 3B ). Therefore, from these data, we concluded that human LAT is proteolytically cleaved at Asp 126 , Asp 138 and Asp 186 ( Figure 3C ). This also suggests that mutation of Asp 138 and Asp 186 leads to the appearance of a cryptic cleavage site centred on Asp 126 . 
Fas engagement prevents TCR-mediated intracellular signalling
Given . Similarly, phosphorylation of ERK and PLC-γ 1 were not affected by mutation of aspartic acid residues in LAT ( Figure 4B ). Moreover, similar Ca 2 + influxes were generated on TCR cross-linking in JCaM2 cells expressing wild-type LAT or LAT 3DA molecules ( Figure 4C ). Therefore mutation of Asp 126 , Asp 138 and Asp 186 does not affect LAT signalling capabilities.
We (results shown in Figure 4A ) and others [23, 27] have observed that treatment with anti-Fas antibody for 90 min inhibited phosphorylation of LAT tyrosine residues. Unexpectedly, the 'uncleavable' LAT 3DA mutant showed the same inhibition of its phosphorylation as the wild-type form ( Figure 4A ). Accordingly, Fas-mediated inhibition of ERK and PLC-γ phosphorylation was comparable in JCaM2 expressing wild-type LAT molecules and LAT 3DA molecules ( Figure 4B ). Moreover, Fas-mediated inhibition of Ca 2 + influx generated after CD3 cross-linking was similar in JCaM2 cells expressing wildtype LAT and LAT 3DA ( Figure 4C ). 
Treatment with H 2 O 2 , anti-CD3 antibodies or pervanadate inhibits Fas-mediated cleavage of LAT
As demonstrated previously, the function of LAT as a docking platform for intracellular signal transduction depends mainly on phosphorylation of its four C-terminal tyrosine residues [1, 9, 10, 30, 31] . Strikingly, the aspartic acid residues at which LAT is cleaved are located close to several of these relevant tyrosine residues, raising the possibility that their phosphorylation could have a regulatory role over LAT cleavage. To induce a robust phosphorylation of LAT before Fas engagement, transfected JCaM2 cells were treated with either anti-CD3 antibodies or H 2 O 2 , since both stimuli have been shown to induce proteintyrosine phosphorylation of several substrates including LAT [32] [33] [34] . Interestingly, treatment with 11 mM H 2 O 2 for 5 min before Fas engagement totally abrogated LAT cleavage (upper panel, Figure 5A ). Moreover, treating cells for 5 min with anti-CD3 before Fas engagement also induced a moderate reduction in LAT cleavage, which was more evident when cells were treated with 10 ng/ml anti-Fas antibody (upper panel, Figure 5A ). The reduced effect of CD3 engagement on LAT cleavage with regard to H 2 O 2 treatment could be due to the higher ability of the latter to induce tyrosine phosphorylation of intracellular substrates (middle lanes, Figure 5A ). We also analysed the effect of pervanadate pretreatment over LAT cleavage, since this constitutes a different method for inducing its phosphorylation [35] . As shown in Figure 5(B) , pre-treatment of JCaM2 cells with freshly prepared 1 % pervanadate strongly inhibited Fas-mediated cleavage of LAT. Then, we analysed the inhibitory effect of LAT phosphorylation over its cleavage in mouse thymocytes. Given that anti-CD3 treatment induces LAT cleavage in thymocytes, we performed H 2 O 2 pre-treatment before incubation with medium alone or antiFas antibody. Consistent with the results obtained in transfected JCaM2 cells, H 2 O 2 pre-treatment clearly reduced LAT cleavage: generation of proteolytic bands on 1-h incubation with medium alone or anti-Fas antibody is almost totally abrogated in H 2 O 2 pre-treated thymocytes ( Figure 5C ).
It has been proposed that the Fas-triggered cleavage of other adaptor molecules such as Gads could be a mechanism for uncoupling signalling pathways downstream of the TCR-CD3 complex during apoptosis, preventing the transduction of survival signals [26] . In this context, breakdown of LAT is of great interest since LAT acts upstream of Gads. Moreover, the specific inhibitory effect of H 2 O 2 and anti-CD3 mAb pre-treatment over Fas-triggered cleavage of LAT suggests that phosphorylation could be a negative feedback mechanism acting over the cleavage of this molecule. In such a model, activation of T-cells through the TCR-CD3 complex leads to LAT phosphorylation, preventing the cleavage that would disrupt TCR-mediated activation signals. In order to verify this model, we analysed the effect of pervanadate pre-treatment of cells again, but in order to achieve a more specific effect, transfectant cells were pre-incubated with pervanadate for 5 min and then pervanadate was diluted 20 times before incubation with anti-Fas antibody. As shown in Figure 6 , preincubation of wild-type LAT expressing cells with pervanadate inhibited its Fas-triggered cleavage. The inhibitory effect of pervanadate, however, was not as strong as that observed for H 2 O 2 ( Figure 5A ), probably owing to the fact that concentration of H 2 O 2 was maintained during the incubation with anti-Fas antibody. Indeed, by maintaining pervanadate concentration during the 4-h incubation with anti-Fas, LAT cleavage was almost totally inhibited (see Figure 5B) . We further examined the pervanadate effect on LAT cleavage in VL3-3M2 cells, an immortalized CD4 + CD8 + cell line derived from a mouse thymic lymphoma [36] . As shown in Figure 5 (D), VL3-3M2 cells pre-treated for 10 min with 2 % pervanadate results in a small reduction in the LAT cleavage induced by etoposide treatment. The weak effect observed of pervanadate pre-treatment is probably due to the fact that upon pre-treatment with 2 % pervanadate cells were washed in order to remove it, and then incubated for 8 h in the presence of etoposide. Indeed, sustained low-dose pervanadate treatment of VL3-3M2 cells totally abrogated LAT cleavage, and LAT phosphorylation was evident. This effect is specific for LAT since PARP cleavage (a typical marker of apoptosis) is not affected by pervanadate treatment ( Figure 5D ).
Interestingly, anti-CD3 mAb treatment of thymocytes, but not in T-lymphocytes or Jurkat cells, induces LAT cleavage. It is widely accepted that TCR-CD3-mediated stimulation induces phosphorylation of LAT, which should protect it from cleavage. It is conceivable that the outcome of TCR engagement in thymocytes is different from mature T-cells, with negative-selecting strong signals leading to LAT cleavage. Given that stimulation of thymocytes with anti-CD3 mAb induce cell death even at low concentrations, we treated the VL3-3M2 thymocyte cell line (known to be resistant to CD3-induced apoptosis) with platebound anti-CD3 mAb or etoposide. As shown in Figure 6 (A), treatment of VL3-3M2 cells with anti-CD3 antibodies does not induce LAT cleavage following etoposide treatment, but it induces the expression of CD69, a typical marker of positive selection ( Figure 6B ). Therefore, this result, together with the effect of sustained low-dose pervanadate treatment over LAT phosphorylation and cleavage, supports the view that during thymic development the interplay between LAT phosphorylation and cleavage could have an important role for positive and negative selection.
In addition, in order to confirm the inverse relationship between phosphorylation and cleavage, we mutated tyrosine residues of LAT located near aspartic acid residues by which it is cleaved (Tyr 127 , Tyr 132 , Tyr 171 , Tyr 191 and Tyr 226 , see Figure 3A ), generating the LAT 5YF (Y127F/Y132F/Y171F/Y191F/Y226F) mutant. Mutation of the five C-terminal tyrosine residues reduces the inhibitory effect granted by pervanadate pre-treatment (see the intensity of the proteolytic bands marked with arrows, Figure 7A ). Figure 7 (B) represents the quantification of upper and lower proteolytic bands of LAT in six independent experiments using JCaM2.5 cells expressing wild-type LAT or the LAT 5YF mutant. The upper and lower proteolytic bands were quantified by densitometry following Fas and Fas plus pervanadate treatments, and the inhibition of their appearance after pervanadate treatment was calculated. As it can be seen, pervanadate diminished the intensity of both proteolytic bands in wild-type LAT expressing cells, but mutation of the five C-terminal tyrosine residues decreased the effect of pervanadate, with a P value lower than 0.05.
Therefore these results support a model in which LAT phosphorylation would negatively regulate its cleavage, counteracting the inhibition of proximal TCR signalling elicited by Fas engagement.
Relationship between anergy induction and LAT cleavage
Clonal anergy is a process triggered by TCR engagement in the absence of co-stimulatory signals and leading to the uncoupling of antigen receptors from their downstream signalling pathways [ 37, 38] . It has been proposed that proteolytic mechanisms are implicated in the uncoupling of the TCR-CD3 complex from intracellular signalling machinery that takes place during anergy [17, 39] . Therefore, given the central role of LAT for transducing signals from the TCR, we sought to study its cleavage in anergic T-cells. Accordingly, PBMCs from healthy donors were cultured in the presence of PHA and IL-2, and then anergy was induced in purified CD4 T-cells by 1 μM ionomycin for 20 h. Anergy was evaluated in these cells by their proliferative capacity in response to plate-bound anti-CD3 and anti-CD28 antibodies. As shown in Figure 7 (A), ionomycin-treated PBMCs have a clearly diminished proliferative capacity when compared with untreated cells. Interestingly, anergy induction induced cleavage of LAT in the absence of any other stimulus ( Figure 7B ), but treatment with anti-CD3 or anti-Fas antibodies did not enhance LAT cleavage. Therefore, these data further support a model by which LAT cleavage could be one of the mechanisms involved in uncoupling TCR from intracellular activatory signals, contributing to maintain peripheral tolerance.
DISCUSSION
LAT is an essential membrane adaptor co-ordinating assembly of signalling complexes on TCR engagement of T-lymphocytes [4] , and is also crucial for proper thymic development [40] . Most of the activatory capacity of LAT seems to relay in its four Cterminal tyrosine residues [1, 30] . However, LAT also constitutes a negative regulator of TCR signalling, since two strains of knockin mice harbouring mutant forms of LAT for several of its tyrosine residues showed a Th2 lymphoproliferative disease [9] [10] [11] . This paradoxical finding revealed that LAT also constitutes a negative regulator of TCR signalling whose molecular base is not known.
As demonstrated previously, LAT and Gads are cleaved following Fas cross-linking in Jurkat cells [26] , and cleavage of Gads has been proposed as a mechanism for the negative regulation of TCR signalling. In the present study, we demonstrated that LAT cleavage occurs not only in Jurkat cells, but also in activated T-lymphocytes, mouse thymocytes and anergic T-cells in response to apoptotic stimuli.
Interestingly, LAT is cleaved in thymocytes in the absence of any treatment, and also on CD3 cross-linking. In agreement with previous data reporting caspase 8 activity in double positive thymocytes [41] , the degree of LAT cleavage is higher in thymocytes when compared with peripheral T-lymphocytes, with untreated thymocytes showing a fast degradation that does not occur in peripheral T-cells or Jurkat cells. It is widely accepted that T-cell development requires the appropriate transduction of TCR-associated signals: high-strength binding of the TCR to its MHC peptide leads to cell death, whereas intermediate affinity interactions lead to survival and differentiation. In this context, cleavage of LAT could constitute a mechanism controlling the intensity of intracellular signals triggered by the TCR. It is conceivable that strong signals could lead to LAT cleavage preventing survival signals from the TCR, whereas weak signals would not trigger breakdown, allowing the transduction of signals leading to positive selection of thymocytes. Further work has to be accomplished in order to clarify the role of LAT cleavage in essential events of T-cell development.
We have also observed that LAT shows cleavage in anergic T-cells. It has been described previously that in anergic T-cells, Gads and Vav-1 are proteolytically cleaved as a result of caspase 3 activation, and that such events could be at the base of the state of hyporesponsiveness of these cells [39] . Given the upstream position of LAT with regard to Gads or Vav-1, and the fact that Lck and ZAP-70 seem not to be cleaved in anergic T-cells (results not shown), LAT cleavage could contribute significantly to inhibiting the TCR signalling cassette.
Also, the present data suggest that caspase 8, granzyme B or a protease with a similar specificity cleaves LAT on Fas engagement in both Jurkat cells and mouse thymocytes. This conclusion is also supported by the sequence found in LAT cleavage sites (Asp-Glu-Asp-Asp 126 , Val-Leu-Pro-Asp 138 and AlaSer-Leu-Asp 186 ), as the three sites found are in a good consensus for granzyme B recognition as shown by Wee et al. [42] , and the analysis of LAT sequence in the GRASVM server (http://www. casbase.org/grasvm/index.html) show the three cleavage sites that we found for LAT.
Interestingly, the proximity of these aspartic acid residues to important tyrosine residues raised the question of a potential relationship between LAT cleavage and transduction of intracellular signals. Therefore it was of interest to evaluate whether the 'uncleavable' mutant LAT 3DA retains any signalling [23, 27] , our results show that Fas engagement produced a significant decrease in the TCRdependent activation of ERK, PLC-γ or Ca 2 + mobilization in both wild-type and mutant LAT 3DA expressing cells, and phosphorylation of LAT tyrosine residues were equally inhibited in both types of cells. This could be explained by the fact that other signalling molecules such as ζ -chain, Gads or SLP-76 are cleaved following Fas engagement, hampering TCR-mediated signalling [26, 27, 43, 44] .
In this context, inhibition of LAT cleavage by incubation with H 2 O 2 or pervanadate is of striking interest. LAT phosphorylation could be a negative regulator of its own cleavage, allowing transduction of activation and survival signals that would counteract apoptotic signals from the Fas receptor. Such a negative effect of phosphorylation over proteolytic cleavage has already been described for other proteins such as IκB-α (inhibitor of nuclear factor κB) [45] or Bid [46] . Although we cannot totally exclude that inhibition of LAT cleavage by H 2 O 2 or pervanadate is due to an inhibitory role of oxidative stress over proteases cleaving LAT, it has been described that H 2 O 2 has an activatory effect over caspases, supporting the view that inhibition of LAT cleavage could be due to its phosphorylation [47, 48] . In support to this model, we show a reduced inhibitory effect of pervanadate treatment in the LAT 5YF mutant, in which its five C-terminal tyrosine residues have been mutated, preventing their phosphorylation and, consequently, its putative inhibitory effect over cleavage. However, by maintaining the pervanadate or H 2 O 2 during anti-Fas treatment, cleavage of LAT 5YF mutant was also totally inhibited (results not shown). This could be due to the remaining tyrosine residues in the LAT 5YF molecule; alternatively, pervanadate might induce a double effect directly inhibiting tyrosine phosphatases, but indirectly activating serine/threonine kinases that could in turn phosphorylate LAT. However, mutation of functionally relevant Ser 38 , Ser 40 , Ser 106 , Ser 164 and Ser 180 had no effect on the inhibition of LAT cleavage mediated by pervanadate (results not shown), but some of the remaining 28 serine residues or nine threonine residues of LAT could be implicated.
In summary, our results suggest an inverse correlation between LAT phosphorylation and its cleavage. It has been previously shown that LAT is able to bind to the open/active isoform of Lck, and this interaction seems to negatively regulate Lck kinase [49] . Interestingly, Kabouridis et al. [50] have recently demonstrated that interaction between LAT and the open form of Lck is mediated by a negatively charged stretch between amino acids 112 and 126 of LAT. Therefore LAT cleavage at Asp 126 would leave a proteolytic fragment still able to bind Lck, and this could constitute a new mechanism for negative regulation of the TCR-CD3 signalling cassette. Moreover, this group has also shown that a truncated form of LAT ending at residue 136 co-immunoprecipitated more efficiently with Lck than fulllength LAT, possibly because in this truncated form the acidic domain is better exposed for association with Lck. The striking similarity between this 136-truncated LAT and the putative LAT-138 truncated form of LAT that is generated following Fas engagement suggests a new mechanism by which the Fas pathway can regulate TCR-mediated activation.
